FDA 3542a Patent Information Submitted with an NDA, or Supplement

Applications for FDA Approval to Market a New Drug

0001 Form FDA 3542a_Dyn_Sec_Ext_07-17-2023

Subpart B - Applications

OMB: 0910-0001